title: [EGFR testing: state of organizations in France in 2010].
authors.affiliation: Institut National du Cancer, 52, avenue André Morizet, 92513 Boulogne-Billancourt cedex, France. f.nowak@institutcancer.fr
authors.forename: F
authors.initials: F
authors.lastname: Nowak
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000235:genetics; D035843:Biomedical Research; D001984:Bronchial Neoplasms / Q000188:drug therapy / Q000235:genetics*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000235:genetics*; D066246:ErbB Receptors / Q000235:genetics*; D005602:France; D018773:Genes, erbB-1 / Q000235:genetics*; D005820:Genetic Testing / Q000639:trends; D006077:Government Agencies; D006801:Humans; D007755:Laboratories, Hospital / Q000458:organization & administration* / Q000639:trends; D009154:Mutation; D009369:Neoplasms / Q000235:genetics; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D066246:ErbB Receptors